Compare NOTV & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOTV | BDL |
|---|---|---|
| Founded | 1974 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 62.6M |
| IPO Year | 1997 | 1995 |
| Metric | NOTV | BDL |
|---|---|---|
| Price | $0.31 | $33.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 534.6K | 819.0 |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.63% |
| EPS Growth | 49.64 | ★ 49.72 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $547,656,000.00 | $205,248,000.00 |
| Revenue This Year | $5.28 | N/A |
| Revenue Next Year | $5.42 | N/A |
| P/E Ratio | ★ N/A | $78.37 |
| Revenue Growth | ★ 511.19 | 8.99 |
| 52 Week Low | $0.25 | $22.61 |
| 52 Week High | $3.35 | $35.98 |
| Indicator | NOTV | BDL |
|---|---|---|
| Relative Strength Index (RSI) | 35.87 | 55.47 |
| Support Level | $0.25 | $29.56 |
| Resistance Level | $0.65 | $34.61 |
| Average True Range (ATR) | 0.03 | 0.53 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 36.86 | 91.07 |
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.